Wegovy Pill vs Injection: Dosing Rules, Results, Cost and How They Compare (2026)

Short answer: the Wegovy pill and the Wegovy injection contain the same medicine, semaglutide, from Novo Nordisk. The pill is a 25 mg tablet taken every morning on an empty stomach; the injection is a 2.4 mg (or 7.2 mg) shot once a week.^[1] In their own placebo trials, body weight fell by an average of 13.6% over 64 weeks on the pill and 14.9% over 68 weeks on the 2.4 mg injection; no trial has compared the two directly.^[1][2] As of November 13, 2026, Novo Nordisk's self-pay price is $149 to $299 a month for the pill and $349 to $399 for the injection.^[3]

Which form suits a person is a decision for that person and their prescriber, and either works best alongside eating well on a smaller appetite, the subject of our guide to what to eat when you're eating less. General information, not medical advice. Everything below comes from the FDA label, the published trials and Novo Nordisk's own price pages, as of November 13, 2026.

Wegovy pill vs injection at a glance

	Wegovy pill (tablets)	Wegovy injection
Active ingredient	Semaglutide, with an absorption enhancer (SNAC)[1]	Semaglutide[1]
FDA approval	December 22, 2025[4]	June 4, 2021; the 7.2 mg dose in March 2026[4]
How it is taken	One tablet a day, by mouth[1]	One shot a week, under the skin, with a single-dose pen[1]
Food and water rule on the label	Morning, empty stomach, with up to 4 oz of plain water; wait at least 30 minutes before food, drinks or other oral medicines[1]	Any time of day, with or without meals[1]
Label dose range	Starts at 1.5 mg; 4 mg, 9 mg, then 25 mg maintenance[1]	Starts at 0.25 mg; maintenance 1.7 or 2.4 mg, up to 7.2 mg for adults[1]
Approved for	Chronic weight management and lowering heart attack, stroke and cardiovascular death risk, in adults[1]	The same two in adults, plus weight management from age 12 and MASH with moderate to advanced liver fibrosis[1]
Main placebo trial	OASIS 4, 64 weeks: body weight −13.6% vs −2.4% on placebo (label figures)[1][2]	STEP 1, 68 weeks: −14.9% on 2.4 mg vs −2.4%.[5] STEP UP, 72 weeks: −18.8% on 7.2 mg[1]
Most common digestive adverse events (drug vs placebo)	OASIS 4: nausea 46.6% vs 18.6%; vomiting 30.9% vs 5.9%; constipation 20.1% vs 9.8%; diarrhea 17.6% vs 8.8%[6]	2.4 mg label: nausea 44% vs 16%; diarrhea 30% vs 16%; vomiting 24% vs 6%; constipation 24% vs 11%[1]
Stopped for an adverse reaction	6.9% vs 5.9% on placebo[1]	6.8% vs 3.2% on placebo (2.4 mg)[1]
Boxed warning	The same on both: risk of thyroid C-cell tumors, seen in rodents, human relevance unknown. Not for anyone with a personal or family history of medullary thyroid carcinoma or with MEN 2.[1]
Self-pay price (November 2026)	$149 a month for 1.5 mg, $199 for 4 mg, $299 for 9 or 25 mg[3]	$349 a month for 0.25 to 2.4 mg, $399 for 7.2 mg; new patients $199 for the first two fills of 0.25 or 0.5 mg[3]

The trial rows come from separate trials in different people over different lengths of time, so they are not a head-to-head result. The full semaglutide story, including Ozempic and Rybelsus, is on our semaglutide reference page, and every GLP-1 medicine, approved or in trials, is mapped in GLP-1 medications explained.

Is the Wegovy pill the same as the shot?

Same molecule, different route. Both forms are semaglutide, a long-acting copy of the gut hormone GLP-1 that acts on appetite centers in the brain and slows stomach emptying.^[1] The tablet adds an absorption enhancer called SNAC so that some semaglutide survives the stomach, and only some does: the label puts absolute bioavailability at about 1% to 2% for the tablet, against 89% for the injection.^[1] That is why the tablet dose is 25 mg a day, against 2.4 mg a week by injection.

In people without type 2 diabetes, average semaglutide levels in the blood were similar on the 25 mg tablet and the 2.4 mg injection. In people with type 2 diabetes they were lower on the tablet, and levels varied more from person to person on the tablet in every group, so the label suggests a prescriber consider the injection for someone with type 2 diabetes who does not respond well to the tablet.^[1] The tablet has not been studied for weight reduction in adults with type 2 diabetes.^[1]

The Wegovy pill is not Rybelsus. Rybelsus and the newer Ozempic tablets are lower-dose semaglutide tablets approved for type 2 diabetes, and they are not interchangeable with the Wegovy pill.^[7]

Wegovy pill dosing rules: what the label says

The tablet's routine is the biggest practical difference. The label's instructions, reproduced so you can see what it says, not so you can follow them yourself:

• Take one tablet in the morning on an empty stomach, with water only, up to 4 ounces (about half a cup). No other liquid.^[1]
• Swallow it whole; do not split, crush or chew it. No more than one tablet a day.^[1]
• Wait at least 30 minutes before eating, drinking anything else or taking other oral medicines.^[1] In a dosing study, more semaglutide was absorbed after a longer fasting period.^[1]
• A missed tablet is skipped; the next one is taken the following day.^[1]

The injection has none of these conditions: once a week, any time of day, with or without meals. A missed weekly dose can be taken if the next one is more than 2 days away.^[1] What the tablet's 30-minute window means for a morning coffee is covered in coffee on a GLP-1.

What the FDA label says — not dosing advice; your prescriber sets your dose.^[1]

	Wegovy pill (daily)	Wegovy injection (weekly)
Starting dose	1.5 mg for 30 days	0.25 mg for 4 weeks
Steps	4 mg, then 9 mg, 30 days each	0.5, 1 and 1.7 mg, 4 weeks each
Maintenance	25 mg	2.4 mg (or 1.7 mg); up to 7.2 mg for adults after at least 4 weeks on 2.4 mg
Missed dose	Skip it; take the next day's tablet	Take it if the next dose is more than 2 days away

Does the Wegovy pill work as well as the injection?

Nobody has tested that head to head. What exists is one placebo trial for each, and their averages are close:

Placebo-controlled result	Pill, 25 mg (OASIS 4, 64 weeks)	Injection, 2.4 mg (STEP 1, 68 weeks)
People randomized	307 adults without diabetes	1,961 adults without diabetes
Average change in body weight	−13.6% vs −2.4%	−14.9% vs −2.4%
Reached a 10% reduction or more	59.8% vs 14.4%	66.1% vs 12%
Reached a 15% reduction or more	47% vs 5.5%	47.9% vs 4.8%
Reached a 20% reduction or more	27.9% vs 3.1%	30.2% vs 1.7%

Sources: the Wegovy label's tables for each study,^[1] the OASIS 4 paper^[2] and the STEP 1 paper.^[5] The OASIS 4 paper reports the placebo figure as −2.2%; the label reports −2.4%.^[2][1] Both trials were funded by Novo Nordisk.^[2][5]

Two more points. The injection goes higher: in STEP UP, the 7.2 mg dose reached −18.8% at 72 weeks, against −15.5% on 2.4 mg and −3.9% on placebo; the tablet has no equivalent higher dose.^[1] And the injection's approvals beyond body weight are broader: MASH and use from age 12 are on the injection's label only.^[1]

Wegovy pill vs injection side effects

The pattern is the same on both: digestive reactions are the most common, mostly while the dose is being raised.^[1] The label says the types and frequency of common adverse reactions in the tablet trial were similar to those seen with the injection.^[1]

Adverse event (drug vs placebo)	Pill, 25 mg (OASIS 4)	Injection, 2.4 mg (label pool)
Nausea	46.6% vs 18.6%	44% vs 16%
Vomiting	30.9% vs 5.9%	24% vs 6%
Diarrhea	17.6% vs 8.8%	30% vs 16%
Constipation	20.1% vs 9.8%	24% vs 11%
Indigestion (dyspepsia)	18.1% vs 8.8%	9% vs 3%
Any digestive adverse event	74.0% vs 42.2%	Not reported as one figure
Stopped for an adverse reaction	6.9% vs 5.9%	6.8% vs 3.2%
Gallstones	2.5% vs 1%	1.6% vs 0.7%
Unusual skin sensations (dysesthesia)	5% vs 0%	2% vs 1% (22% on the 7.2 mg dose)

Sources: ClinicalTrials.gov results for OASIS 4,^[6] the OASIS 4 paper for the digestive total,^[2] and the Wegovy label for the rest.^[1] These are separate trials, so the columns are not a ranking.

Two label points apply to the tablet only. Because semaglutide slows the stomach and the tablet is taken by mouth alongside other morning medicines, the label notes that levothyroxine exposure rose 33% when taken with the tablet in a study, and advises monitoring other oral medicines.^[1] And breastfeeding is not recommended on the tablet, because its absorption enhancer passes into breast milk.^[1] The other warnings, including pancreatitis, gallbladder disease, kidney injury from dehydration and low blood sugar with insulin or a sulfonylurea, apply to both forms.^[1] For the weeks after a dose step, our guide to eating on queasy days covers food that tends to sit well.

Wegovy pill vs injection cost

Prices change often. These are Novo Nordisk's own figures, read on November 13, 2026.

• Pill, self-pay: $149 a month for 1.5 mg, $199 for 4 mg and $299 for 9 mg or 25 mg, a month being one bottle of 30 tablets.^[3]
• Injection, self-pay: $349 a month for any dose from 0.25 to 2.4 mg, and $399 for the 7.2 mg dose (Wegovy HD). New patients pay $199 a month for their first two fills of 0.25 or 0.5 mg, through December 31, 2026.^[3]
• With commercial insurance that covers it: either form can cost as little as $25 a month with Novo's savings offer, up to $100 a month in savings.^[3]
• List price: Novo Nordisk will cut the list price of Wegovy to $675 a month from January 1, 2027, and said the change does not affect self-pay prices.^[8]

So at the maintenance doses, the pill is $50 a month cheaper than the 2.4 mg injection when paying out of pocket ($299 vs $349). Medicare Part D is barred by law from covering drugs used for obesity alone,^[9] and the CMS Medicare GLP-1 Bridge, from July 1, 2026 to December 31, 2027, gives eligible Part D beneficiaries certain GLP-1 drugs for a $50 copay, with prior authorization.^[10]

Switching between the Wegovy pill and the injection

This is the one switch the label spells out, because both forms are the same product:^[1]

• From the 2.4 mg injection to the pill: start the 25 mg tablet one week after the last injection.
• From the 25 mg pill to the injection: start the 2.4 mg injection the day after the last tablet; for someone who did not tolerate the 25 mg tablet, the label says to consider the 1.7 mg injection.
• Not together: the label says not to use either form with any other semaglutide product or any other GLP-1 receptor agonist.

Whether and when to switch is your prescriber's decision.

Who might prefer which

These are the differences a prescriber weighs, from the label and the price pages; the choice itself belongs to you and your prescriber.

• Needles. The pill avoids injections entirely.^[1]
• Mornings. The pill asks for an empty stomach, a small amount of water and a 30-minute wait every day; the injection asks for nothing on six days of the week.^[1]
• Other daily medicines. Anyone who takes levothyroxine or other morning pills has the tablet's timing and the label's monitoring note to consider.^[1]
• Type 2 diabetes. The tablet was not studied for weight reduction in type 2 diabetes, and blood levels were lower on it in that group.^[1]
• Dose ceiling. Only the injection goes beyond 2.4 mg, to 7.2 mg.^[1]
• Age and liver disease. Teens 12 and up and MASH are on the injection's label only.^[1]
• Cost. Self-pay, the pill is $149 to $299 a month and the injection $349 to $399.^[3]

What about Foundayo, the other GLP-1 pill?

Foundayo (orforglipron, Eli Lilly) is the second GLP-1 pill approved for chronic weight management, approved on April 1, 2026.^[11] It is a different molecule, a small-molecule drug rather than a peptide, and its label says to take it "with or without food," with no water limit or waiting time.^[12] No trial comparing it directly with the Wegovy pill for body weight has reported. Its trials, doses and prices are on our orforglipron (Foundayo) page, and the injectable alternative from Lilly is compared in Zepbound vs Wegovy.

What to eat on either form

The label pairs both forms with a reduced-calorie diet and more physical activity, and names no specific diet.^[1] The 2025 joint advisory from four US medical and nutrition societies sets the same priorities for every GLP-1 medication: protein first, small nutrient-dense meals, fiber from food, deliberate fluids and strength training to protect lean mass.^[13] On the pill, the first meal of the day simply comes at least 30 minutes after the tablet.^[1]

• What to eat on Wegovy: a sample small-appetite day, with amounts.
• How much protein on a GLP-1, by body weight, and the protein calculator.

For transparency about why this page exists on our site: we make one product, Zornava Replenish, a lemon-lime daily hydration and nutrient powder for lighter appetite days, including for people on GLP-1 medications. It is a dietary supplement, not a medication, and it does not replace or imitate any medicine on this page. It is not on sale yet; early access opens February 9, 2027, and the early-access list is open now.